4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023982
President and CEO bought 14,288 shares at $5.91 ($84,465)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2019-09-18 | Purchase | +14,288 | $5.91 | $84,465 | 614,826 | D |
| Open-market purchases · 14,288 sh · avg $5.91 · $84,465 | |||||||
Loading xslF345X03/doc4.xml…